Patents by Inventor Brian J. LANNUTTI

Brian J. LANNUTTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPIES FOR HEMATOLOGIC MALIGNANCIES
    Publication number: 20200368243
    Abstract: The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administering a compound of formula A, wherein R is H, halo, or C1-C6 alkyl; R? is C1-C6 alkyl; or a pharmaceutically acceptable salt thereof; and optionally a pharmaceutically acceptable excipient; and administering at least one additional therapeutic agent.
    Type: Application
    Filed: August 10, 2020
    Publication date: November 26, 2020
    Inventors: W. Michael GALLATIN, Roger G. ULRICH, Neill A. GIESE, Brian J. LANNUTTI, Langdon MILLER, Thomas M. JAHN
  • THERAPIES FOR TREATING CANCERS
    Publication number: 20160331754
    Abstract: Provided herein are methods, compositions, and kits for treating myeloproliferative disorders or neoplasms, including polycythemia vera, primary myelofibrosis, thrombocythemia, and essential thrombocythemia. Also provided herein are methods for treating cancers. Such methods may include the use of a JAK inhibitor and a PI3K inhibitor. Such methods may include the use of an anti-CD20 antibody and a PI3K inhibitor. Provided herein are also compositions, articles of manufacture and kits related thereto.
    Type: Application
    Filed: January 19, 2015
    Publication date: November 17, 2016
    Inventors: Roger Dansey, Ronald L. Dubowy, Brian J. Lannutti, Sarah Meadows, Christophe Queva
  • THERAPIES FOR TREATING CANCER
    Publication number: 20140051696
    Abstract: Provided herein are methods that relate to a novel therapeutic strategy for treatment of cancer, including hematological malignancies such as leukemia, lymphoma, and multiple myeloma. In particular, the method includes administration of a PI3K? inhibitor and a Syk inhibitor.
    Type: Application
    Filed: August 14, 2013
    Publication date: February 20, 2014
    Applicant: GILEAD CALISTOGA LLC
    Inventors: Brian J. LANNUTTI, Julie DI PAOLO, Heather WEBB, Adam KASHISHIAN